|
1
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Meyer MA: Malignant gliomas in adults. N
Engl J Med. 359:18502008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim SH, Ezhilarasan R, Phillips E,
Gallego-Perez D, Sparks A, Taylor D, Ladner K, Furuta T, Sabit H,
Chhipa R, et al: Serine/threonine kinase MLK4 determines
mesenchymal identity in glioma stem cells in an NF-κB-dependent
manner. Cancer Cell. 29:201–213. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cheng P, Wang J, Waghmare I, Sartini S,
Coviello V, Zhang Z, Kim SH, Mohyeldin A, Pavlyukov MS, Minata M,
et al: FOXD1-ALDH1A3 signaling is a determinant for the
self-renewal and tumorigenicity of mesenchymal glioma stem cells.
Cancer Res. 76:7219–7230. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Noda SE, El-Jawahri A, Patel D,
Lautenschlaeger T, Siedow M and Chakravarti A: Molecular advances
of brain tumors in radiation oncology. Semin Radiat Oncol.
19:171–178. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Taylor SS, Ha E and McKeon F: The human
homologue of Bub3 is required for kinetochore localization of Bub1
and a Mad3/Bub1-related protein kinase. J Cell Biol. 142:1–11.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Baker DJ, Jeganathan KB, Cameron JD,
Thompson M, Juneja S, Kopecka A, Kumar R, Jenkins RB, de Groen PC,
Roche P, et al: BubR1 insufficiency causes early onset of
aging-associated phenotypes and infertility in mice. Nat Genet.
36:744–749. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dai W, Wang Q, Liu T, Swamy M, Fang Y, Xie
S, Mahmood R, Yang YM, Xu M and Rao CV: Slippage of mitotic arrest
and enhanced tumor development in mice with BubR1
haploinsufficiency. Cancer Res. 64:440–445. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Q, Liu T, Fang Y, Xie S, Huang X,
Mahmood R, Ramaswamy G, Sakamoto KM, Darzynkiewicz Z, Xu M, et al:
BUBR1 deficiency results in abnormal megakaryopoiesis.
Blood. 103:1278–1285. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kops GJ, Foltz DR and Cleveland DW:
Lethality to human cancer cells through massive chromosome loss by
inhibition of the mitotic checkpoint. Proc Natl Acad Sci USA.
101:8699–8704. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wan X, Yeung C, Kim SY, Dolan JG, Ngo VN,
Burkett S, Khan J, Staudt LM and Helman LJ: Identification of
FoxM1/Bub1b signaling pathway as a required component for growth
and survival of rhabdomyosarcoma. Cancer Res. 72:5889–5899. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Raychaudhuri P and Park HJ: FoxM1: A
master regulator of tumor metastasis. Cancer Res. 71:4329–4333.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Monteiro LJ, Khongkow P, Kongsema M,
Morris JR, Man C, Weekes D, Koo CY, Gomes AR, Pinto PH, Varghese V,
et al: The Forkhead Box M1 protein regulates BRIP1 expression and
DNA damage repair in epirubicin treatment. Oncogene. 32:4634–4645.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu M, Dai B, Kang SH, Ban K, Huang FJ,
Lang FF, Aldape KD, Xie TX, Pelloski CE, Xie K, et al: FoxM1B is
overexpressed in human glioblastomas and critically regulates the
tumorigenicity of glioma cells. Cancer Res. 66:3593–3602. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Maachani UB, Shankavaram U, Kramp T,
Tofilon PJ, Camphausen K and Tandle AT: FOXM1 and STAT3 interaction
confers radioresistance in glioblastoma cells. Oncotarget.
7:77365–77377. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peng WX, Han X, Zhang CL, Ge L, Du FY, Jin
J and Gong AH: FoxM1-mediated RFC5 expression promotes temozolomide
resistance. Cell Biol Toxicol. Feb 9–2017.(Epub ahead of print).
doi: 10.1007/s10565-017-9381-1. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hudler P, Britovsek NK, Grazio SF and
Komel R: Association between polymorphisms in segregation genes
BUB1B and TTK and gastric cancer risk. Radiol Oncol. 50:297–307.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mansouri N, Movafagh A, Sayad A, Heidary
Pour A, Taheri M, Soleimani S, Mirzaei HR, Shargh Alizadeh S,
Azargashb E, Bazmi H, et al: Targeting of BUB1b gene expression in
sentinel lymph node biopsies of invasive breast cancer in iranian
female patients. Asian Pac J Cancer Prev. 17(S3): 317–321. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hahn MM, Vreede L, Bemelmans SA, van der
Looij E, van Kessel AG, Schackert HK, Ligtenberg MJ, Hoogerbrugge
N, Kuiper RP and de Voer RM: Prevalence of germline mutations in
the spindle assembly checkpoint gene BUB1B in individuals with
early-onset colorectal cancer. Genes Chromosomes Cancer.
55:855–863. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fu X, Chen G, Cai ZD, Wang C, Liu ZZ, Lin
ZY, Wu YD, Liang YX, Han ZD, Liu JC, et al: Overexpression of BUB1B
contributes to progression of prostate cancer and predicts poor
outcome in patients with prostate cancer. Onco Targets Ther.
9:2211–2220. 2016.PubMed/NCBI
|
|
21
|
Mao P, Joshi K, Li J, Kim SH, Li P,
Santana-Santos L, Luthra S, Chandran UR, Benos PV, Smith L, et al:
Mesenchymal glioma stem cells are maintained by activated
glycolytic metabolism involving aldehyde dehydrogenase 1A3. Proc
Natl Acad Sci USA. 110:8644–8649. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Z, Zhang G and Kong C: FOXM1
participates in PLK1-regulated cell cycle progression in renal cell
cancer cells. Oncol Lett. 11:2685–2691. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim SH, Joshi K, Ezhilarasan R, Myers TR,
Siu J, Gu C, Nakano-Okuno M, Taylor D, Minata M, Sulman EP, et al:
EZH2 protects glioma stem cells from radiation-induced cell death
in a MELK/FOXM1-dependent manner. Stem Cell Reports. 4:226–238.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee Y, Kim KH, Kim DG, Cho HJ, Kim Y,
Rheey J, Shin K, Seo YJ, Choi YS, Lee JI, et al: FoxM1 promotes
stemness and radioresistance of glioblastoma by regulating the
master stem cell regulator Sox2. PLoS One. 10:e01377032015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ganguly R, Mohyeldin A, Thiel J, Kornblum
HI, Beullens M and Nakano I: MELK-a conserved kinase: Functions,
signaling, cancer, and controversy. Clin Transl Med. 4:112015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Edgar BA and Orr-Weaver TL:
Endoreplication cell cycles: More for less. Cell. 105:297–306.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cortés F, Mateos S, Pastor N and Domínguez
I: Toward a comprehensive model for induced endoreduplication. Life
Sci. 76:121–135. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee HO, Davidson JM and Duronio RJ:
Endoreplication: Polyploidy with purpose. Genes Dev. 23:2461–2477.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kaźmierczak A: Endoreplication in
Anemia phyllitidis coincides with the development of
gametophytes and male sex. Physiol Plant. 138:321–328. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim JA, Lee J, Margolis RL and Fotedar R:
SP600125 suppresses Cdk1 and induces endoreplication directly from
G2 phase, independent of JNK inhibition. Oncogene. 29:1702–1716.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wonsey DR and Follettie MT: Loss of the
forkhead transcription factor FoxM1 causes centrosome amplification
and mitotic catastrophe. Cancer Res. 65:5181–5189. 2005. View Article : Google Scholar : PubMed/NCBI
|
